[难治性塞扎瑞综合征患者治疗结束后莫干单抗对外周血病变的持续作用--病例报告］

Q4 Medicine

Japanese Journal of Cancer and Chemotherapy Pub Date : 2024-08-01

Masahiro Manabe, Hideki Endo, Naoyuki Inano, Yuuji Hagiwara, Satoru Nanno, Ki-Ryang Koh

{"title":"[难治性塞扎瑞综合征患者治疗结束后莫干单抗对外周血病变的持续作用--病例报告］","authors":"Masahiro Manabe, Hideki Endo, Naoyuki Inano, Yuuji Hagiwara, Satoru Nanno, Ki-Ryang Koh","doi":"","DOIUrl":null,"url":null,"abstract":"A 70-year-old man who developed recurrent Stage ⅣA1 Sézary syndrome after first-line treatment received 6 cycles of mogamulizumab treatment. After mogamulizumab treatment completion, persistent effects on peripheral blood lesions were observed. Although Sézary syndrome is a relatively uncommon cutaneous lymphoma, it is important to recognize that the effects of mogamulizumab may not be limited to the treatment course and might be sustained even after treatment completion.","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"51 8","pages":"833-835"},"PeriodicalIF":0.0000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Persistent Effects of Mogamulizumab on Peripheral Blood Lesions after Treatment Completion in a Patient with Refractory Sézary Syndrome-A Case Report].\",\"authors\":\"Masahiro Manabe, Hideki Endo, Naoyuki Inano, Yuuji Hagiwara, Satoru Nanno, Ki-Ryang Koh\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A 70-year-old man who developed recurrent Stage ⅣA1 Sézary syndrome after first-line treatment received 6 cycles of mogamulizumab treatment. After mogamulizumab treatment completion, persistent effects on peripheral blood lesions were observed. Although Sézary syndrome is a relatively uncommon cutaneous lymphoma, it is important to recognize that the effects of mogamulizumab may not be limited to the treatment course and might be sustained even after treatment completion.\",\"PeriodicalId\":35588,\"journal\":{\"name\":\"Japanese Journal of Cancer and Chemotherapy\",\"volume\":\"51 8\",\"pages\":\"833-835\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Japanese Journal of Cancer and Chemotherapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese Journal of Cancer and Chemotherapy","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

一名70岁的男性在接受一线治疗后复发了ⅣA1期塞扎里综合征，接受了6个周期的莫加单抗治疗。莫加单抗治疗结束后，观察到其对外周血病变的持续影响。尽管Sézary综合征是一种相对少见的皮肤淋巴瘤，但我们必须认识到，莫干单抗的作用可能并不局限于治疗过程，甚至在治疗结束后仍会持续。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

[Persistent Effects of Mogamulizumab on Peripheral Blood Lesions after Treatment Completion in a Patient with Refractory Sézary Syndrome-A Case Report].

A 70-year-old man who developed recurrent Stage ⅣA1 Sézary syndrome after first-line treatment received 6 cycles of mogamulizumab treatment. After mogamulizumab treatment completion, persistent effects on peripheral blood lesions were observed. Although Sézary syndrome is a relatively uncommon cutaneous lymphoma, it is important to recognize that the effects of mogamulizumab may not be limited to the treatment course and might be sustained even after treatment completion.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Japanese Journal of Cancer and Chemotherapy Medicine-Medicine (all)

CiteScore

0.20

自引率

0.00%

发文量

337